+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 50Years - 90Years
All Genders
ID06359548

Study Comparing a New Method of Internal Limiting Membrane Reposition to Traditional Peeling for Treating Idiopathic Macular Holes in Adults Aged 50 to 90

Led by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2024-04-11

90

Participants Needed

1

Research Sites

21 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying idiopathic macular holes IMH, a common eye condition mostly affecting people over 60, which causes tissue defects in the photoreceptor layer near the macula and can severely impact vision and quality of life. This trial evaluates a new surgical technique called peeled internal limiting membrane ILM reposition, which aims to better preserve retinal structure and improve outcomes compared to the traditional ILM peeling method used in vitrectomy surgeries. This study is a single-center, prospective, randomized controlled trial designed to compare these two surgical approaches in patients with IMH. The trial includes two groups one receiving the novel peeled ILM reposition procedure, where the ILM flap is carefully peeled and repositioned to maintain retinal integrity, and the other undergoing the traditional ILM peeling technique, which removes the ILM around the macular hole. Both procedures involve staining the ILM with indocyanine green and performing vitrectomy. The peeled ILM reposition uses additional steps to flatten and fix the ILM flap with perfluoron, while the traditional peeling creates a larger peeled area around the foveal center. Participants will be monitored before surgery and at 1, 3, and 6 months after the procedure. Assessments include measuring best corrected visual acuity BCVA changes, macular hole closure rates, retinal thickness, fixation stability, retinal electrical activity mfERG, inner retinal dimpling, and vision-related quality of life using questionnaires. These detailed evaluations aim to determine which surgical method offers better morphological and functional results over six months. The trial enrolls patients aged 50 to 80 with macular holes not exceeding 600 micrometers in diameter.

CONDITIONS

Brief Title

PEELED INTERNAL LIMITING MEMBRANE REPOSITION

Research Team

T

Tian Tian, MD,PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here